课题基金 / 基金详情

Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response

Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
分子靶向放射性核素治疗肿瘤免疫调节和增强免疫治疗反应
批准号:
10672952
负责人:
JAMEY P WEICHERT
金额:
$20.31万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-14 至 2025-05-31

项目摘要

项目成果

JAMEY P WEICHERT的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要-行政核心 行政核心(Admin Core)提供规划所需的业务结构, 所有P01活动的实施和管理,并促进高效,渐进和成功的 与项目目标和P01使命一致。它还提供行政协调, 向所有领导人、共同领导人、调查员和核心主任提供监督和研究支助服务。通过提供 通过集中提供这种支持,管理核心可以提高效率并确保所有P01研究和活动 满足了集中的、相互关联的、复杂的科学目标,并利用了现有的癌症中心资源 而不是复制。最后,管理核心提供所需的项目监督、监控和审计, 确保项目符合与P01研究计划一致的规定终点,并遵守所有法规 要求.一位经验丰富的半职行政助理Shari Piaskowski将担任 P01的行政经理,在威斯康星州大学机构职位奖励工作人员的支持下 中央办公室。
英文摘要
PROJECT SUMMARY – ADMINISTRATIVE CORE The Administrative Core (Admin Core) provides the operational structure necessary for the planning, implementation and management of all P01 activities and promotes the efficient, progressive and successful conduct consistent with the program goals and P01 mission. It also provides administrative coordination, oversight and research support services to all leaders, co-leaders, investigators and core directors. By providing this support centrally, the Admin Core promotes efficiency and ensures that all P01 research and activities are focused and connected, complex scientific objectives are met, and existing cancer center resources are utilized and not duplicated. Finally, the Admin Core provides required project oversight, monitoring and auditing to ensure projects are meeting stated endpoints consistent with the P01 research plan and adhering to all regulatory requirements. An experienced, half-time administrative associate, Shari Piaskowski, will serve as the administrative manager of the P01, with support from institutional post award staff from University of Wisconsin central offices.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
  • 批准号:
    10024889
  • 项目类别:
  • 资助金额:
    $20.66万
  • 财政年份:
    2020
  • 负责人:
    JAMEY P WEICHERT
  • 依托单位:
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
  • 批准号:
    10263245
  • 项目类别:
  • 资助金额:
    $35.81万
  • 财政年份:
    2020
  • 负责人:
    JAMEY P WEICHERT
  • 依托单位:
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
  • 批准号:
    10416049
  • 项目类别:
  • 资助金额:
    $20.31万
  • 财政年份:
    2020
  • 负责人:
    JAMEY P WEICHERT
  • 依托单位:
Novel Molecular Targeted Radionuclide Therapies for Dosimetry-Guided Immunomodulation
  • 批准号:
    10416045
  • 项目类别:
  • 资助金额:
    $35.1万
  • 财政年份:
    2020
  • 负责人:
    JAMEY P WEICHERT
  • 依托单位:
海外基金